Condition: Tricuspid Regurgitation · Sponsor: Abbott Medical Devices
The goal of this observational post approval study is to confirm the safety and efficacy of the TriClip System when used in routine clinical practice in the Japanese population and to fulfill post-market requirements following commercial approval in Japan.
This description comes directly from the study's public registry record.
Jacob Zbinden · +16517564272 · jacob.zbinden@abbott.com
Meghan Griffin · meghan.griffin@abbott.com
Always discuss trial participation with your own doctor first.
| National Cerebral & Cardiovascular Center Hospital | Suita, Osaka, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07509658